| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Nephrology, Transplantology, and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
Spironolactone Attenuates Oxidative Stress in Patients With Chronic Kidney Disease
Marcin Renke;
aw Rutkowski;
ski;
Wo
niak;
aw Rutkowski
Department of Medical Chemistry, Medical University of Gdansk, Gdansk, Poland
Blood Brain Barrier and Neuro-Oncology Program, Oregon Health and Science University, Portland, Ore
This article has been cited by other articles:
![]() |
L. Michea and E. T. Marusic Response to Spironolactone Attenuates Oxidative Stress in Patients With Chronic Kidney Disease Hypertension, November 1, 2008; 52(5): e134 - e134. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |